|Moderator and presenter: Prof. V. Phé (FR)
Presenters: Prof. J.P.F.A. Heesakkers (NL) and Mr. A. Sahai (GB)
Save the date: Tuesday, 21 June 2022
Time: 18:30 – 19:30 CESTThe aim of this webinar is to provide elements based on literature and experts’ experience to guide the choice between sacral neuromodulation or Botulinum toxin A injection in patients suffering from idiopathic refractory OAB.
First, comments will be given on current guidelines on OAB management. Then, strengths and weaknesses of both therapies will be exposed including a critical review of the Rosetta study and long-term results (outcomes of both therapies and discontinuation rate of botulinum toxin A injection). Finally an interactive case will be presented in order to illustrate everyday practice. The objective is to help participants optimise OAB management.